KINAXO Biotechnologies GmbH Company Profile

11:50 EDT 22nd March 2018 | BioPortfolio

KINAXO Biotechnologies is a privately-held biotechnology company based in Munich-Martinsried, Germany. The company is a spin-off from the Max-Planck Institute for Biochemistry in Martinsried. KINAXO offers a comprehensive chemical-proteomics technology - known as KinaTorTM - to identify and characterize the biological interactions of kinase inhibitors with their cellular protein targets. The KinaTorTM-technology was developed and optimized over several years by its founders Dr. Henrik Daub and Dr. Axel Ullrich. Additional founding shareholders are Dr. Hellmut Kirchner, Axel Leimer and Dr. Andreas Jenne, as well as BioM AG and the Max Planck Society. KINAXO has a secure IP position with an exclusive worldwide license to the KinaTorTM-patents for partnering and fee-for-services activities.


Am Klopferspitz 19a


Phone: 49 89 7007638-31
Fax: 49 89 7007638-31

News Articles [203 Associated News Articles listed on BioPortfolio]

#jobs #lifescience FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Development) x 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Developmen...

Adaptive Biotechnologies kündigt Kooperation mit Amgen für den Fortschritt der klinischen Entwicklung des clonoSEQ-Assays bei Multiplem Myelom an

Adaptive Biotechnologies, eines der führenden Unternehmen für die Kombination von Sequenzierung der nächsten Generation (Next-Generation Sequencing, NGS) und durchdachter Bioinformatik für die Pro...

Elanix Biotechnologies: Erfolgreiche Studie

Transwell Biotech, ein Partner von Elanix Biotechnologies, schließt eine Phase-I Studie zur Wundbehandlung bei Hauttransplantaten ab. Das Produkt von Transwell kombiniert ein Hydrogel mit kryokonse.....

Ethrog Biotechnologies Invitrogen iBlot Dry Blotting Gel Transfer System +Manual

$59.99End Date: Thursday Dec-7-2017 11:05:38 PSTBuy It Now for only: $59.99Buy It Now | Add to watch list Biotech365 : Ethrog Biotechnologies Invitrogen iBlot Dry Blotting Gel Transfer System +Ma...

Arbor Biotechnologies Comes Out of Stealth Mode

Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.

Elanix Biotechnologies: Neues zur Kapitalerhöhung

Bei Elanix Biotechnologies steht eine Kapitalerhöhung an. Ausgegeben werden fast 1,7 Millionen neue Aktien. Aktionäre können die Papiere im Verhältnis 4:1 zeichnen. Für vier alte Aktien wird es e...

Azelis and Tagra Biotechnologies Extend Partnership

Israel’s Tagra Biotechnologies has appointed Azelis as the exclusive distributor of its range of Release on Demand (RND) microcapsules for all personal care applications in France and Benelux, w...

ProMab Biotechnologies Acquires One World Lab

ProMab Biotechnologies, a manufacturer of monoclonal antibodies and immunotherapy related products and services, has acquired One World Lab, a marketplace exclusive to manufacturers. SAN DIEGO (PRWEB)...

PubMed Articles [26 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Dental, Oral, and Craniofacial Regenerative Medicine: Transforming Biotechnologies for Innovating Patient Care.

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Clinical Trials [41 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [625 Associated Companies listed on BioPortfolio]

KINAXO Biotechnologies GmbH

KINAXO Biotechnologies is a privately-held biotechnology company based in Munich-Martinsried, Germany. The company is a spin-off from the Max-Planck Institute for Biochemistry in Martinsried. KINAXO o...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc.,, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Open Therapeutics

Open Therapeutics ( is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

More Information about "KINAXO Biotechnologies GmbH" on BioPortfolio

We have published hundreds of KINAXO Biotechnologies GmbH news stories on BioPortfolio along with dozens of KINAXO Biotechnologies GmbH Clinical Trials and PubMed Articles about KINAXO Biotechnologies GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KINAXO Biotechnologies GmbH Companies in our database. You can also find out about relevant KINAXO Biotechnologies GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record